Catholic Medical Quarterly Vol 76 (4) November 2026

And a vigorous debate on Palliative care

Dr Adrian Treloar

Dr TreloarIn our last 2 issues we published articles by Fr Prof Pullicino on care of the dying [1,2]. In the May edition Fr Pullicino (a retired professor of neurology) drew upon a paper by Sy Wilson [3], an Australian financier and data analyst. He is clearly a Covid doubter, who appears to think that Covid did not kill people and the vaccines did harm etc. John Rogers has written excellent articles pointing out his concerns about the Rev Prof Pullicinpo’s papers [4,5].

The core finding of Sy’s paper is a close correlation between Midazolam prescriptions and death within the next 28 days. In all honesty, given the policies in place at the time (NICE guideline 169 in particular and the current guideline “Care of dying adults in the last days of life, NICE guideline :NG31) that data is what we should be seeing and what would be expected. People who were thought to be too unwell for critical care were thought to be dying and anticipatory medicines prescribed.

An important point about anticipatory (or just in case) medicines is that when they  are prescribed, they are not necessarily to be used, they are there “just in case” that dying person suffers and needs them. On the other hand , once prescribed they might be used before they are needed. Certainly it is routine practice to prescribe them to dying people and that is a system which means that doctors and nurses don’t have to scramble around getting scripts at 2am- they can more easily give meds that have already been prescribed and dispensed. As a paramedic, Jon Rogers [4] can also give these meds to symptomatic people who are suffering. And that must be right and good. Although especially perhaps in acute care, medicines which have been prescribed and dispensed just in case they are needed MAY be given when they are not actually needed. That is what (reasonably I think) worries the Rev Prof Pullicino.

Put together, what that means is that the key data relied upon by Pullicino which is provided by Sy (and deeply criticised by Rogers) is almost certainly true. Following NICE guidance on end of life care would mean that we should expect to see midazolam prescribed to many dying people. Sy’s paper concludes that a lot of midazolam was indeed prescribed to people who were thought to be dying of Covid. If anticipatory medicines are set out in NICE guidance as a part of a prescription package on entry to “end of life care”, a close correlation between midazolam prescription and death becomes expected and wholly unsurprising. Which as I have said, may be sign of effective, well written (but possibly harmful) policies and clinical pathways. As Rogers has already stated, Sy does make a number of other very bizarre conclusions, but those were not brought into the paper by Pullicino.

Further, while Sy provided evidence that, in those who did die, Midazolam was widely prescribed, he provides no evidence that midazolam was actually given and no evidence that Midazolam was the cause of death. He makes a simple schoolboy error that close correlation shows causation.

BUT as Rogers points out NICE guideline 159 was developed at the time to enable decision making about who got critical care during Covid. This journal criticised that guideline at the time [5]. The problem was absolutely that by using the Rockwood scale [6], elderly people with even minor memory loss found a guideline that set out to restrict access of that group into critical care. In the Rockwood scale mild frailty is defined as “Mildly Frail – These people often have more evident slowing, and need help in high order IADLs (finances, transportation, heavy housework, medications). Typically, mild frailty progressively impairs shopping and walking outside alone, meal preparation and housework. And mild dementia is defined as “Common symptoms in mild dementia include forgetting the details of a recent event, though still remembering the event itself, repeating the same question/story and social withdrawal. Both those symptom sets get you 5 points on the Rockwood Frailty score and that encouraged clinicians into a non-critical care pathway with “end of life care” as a significantly more likely outcome.

Simply put the concern was that the  “COVID-19 rapid guideline: critical care in adults”, published by NICE, effectively diverted mildly frail elderly people away from critical care and towards an “end of life” care stream. Allied guidance recommended anticipatory medicine prescribing and patients were one step away from injections of morphine and midazolam, with (potentially) no further discussion about need etc. For those who might have otherwise survived, being on the guideline might well have been lethal. There was widespread outrage especially from disability groups for younger people and after a judicial review, the guideline was modified and then withdrawn

We know that midazolam and morphine are both strong respiratory depressants and frail elderly people are especially sensitive to those side effects people with Covid related respiratory failure were even more vulnerable. And we also  know that  they are usually both prescribed as part of the anticipatory medicine package.

So, none of us should really be surprised that prescriptions of midazolam correlated highly with Covid deaths. At that time Midazolam was widely prescribed as an anticipatory medicine for those dying with Covid. But we should not conclude that midazolam caused all deaths within 28 days of Covid. That misreads the data and we should point out that.

Dr Charlie O’Donnell a retired consultant in Emergency and Intensive Care Medicine has written a very wise and article [7] which is both practical and ethically based. He is right, we need common sense when negotiating complex decisions for dying people.

The Rev Prof Pullicino’s use of Sy’s data is I think reasonable. He does not appear to share Sy’s conclusions about the vaccine causing death etc, but he is clearly very worried about the use of midazolam and morphine in elderly frail people. In his conclusion the Rev Prof Pullicino states that [3] EOLC pathways are a form of involuntary euthanasia. They are now effectively a forced end-of-life-diagnosing, dehydrating and life-ending machine which resists all appeals against its decisions. It is the antithesis of Christian care and must be immediately discontinued. The article by James Bogle (a barrister) [8] gives at least some suggestions that the Rev Prof Pullicino has some basis in reality.

As I and multiple authors [3,4, 5, 7] in this issue have felt bound to point out morphine and midazolam are cornerstones of good palliative care. And yet, those medicines do, especially at higher doses, have the ability to assure death as the outcome in those who are not actually dying. Which may well justify Prof Pullicino’s conclusion. I feel personally sure that that happened on some people during the pandemic and that it still happens for others in routine acute care. I first expressed my concerns about the LCP in 2008 [9]. I was very heavily criticised, and the LCP widely supported by experts and national bodies. And yet it had to be withdrawn. The more recent paper [10] cautioning against the use of syringe drivers is therefore heartening. Gosport showed yet again how things can and do go wrong.[10] 456 deaths in association with inappropriate doses of morphine cannot be ignored.

I also remain persuaded that predicting death is tricky, and great care is needed, both to palliate and also to avoid incorrect diagnosis of imminent death.

I remember an elderly man who was diagnosed as dying of liver metastases. His son was on the other side of the world but on his way. He wanted to change his will and I was asked to assess his capacity. But he was on the LCP and even though he was pain free, as per the LCP (version 9 I think) instructions “Syringe driver within 4 hours of doctors order) he was given “just in case” medicines before they were needed. By the time his son arrived he was comatose, obtunded and died soon after. He had been deprived of his consciousness and lost the opportunity to change his will or to see his son again before he died.

Dying well, includes good analgesia and also not being deprived of consciousness. For many it includes saying goodbye to family and friends. I hope that the series of articles in this and the last 2 issues of the CMQ have helped us towards a position that palliative care, well done with adequate analgesia but without unnecessary deprivation of consciousness is terribly important. We must promote good palliative care while also remaining vigilant about poor care of the dying.

Peter (see previous article) went joyfully to his Saviour with the help of excellent palliative care.

End of life care is the wrong term!

One final little rant. End of Life Care is the wrong term. It focusses people on the outcome of the end of life which is death. Palliative care (or perhaps care towards the end of life) should focus us onto living well and comfortably till we die. A good death is to be cherished greatly. As Dame Cicily Saunders said, a good death lives on in the memory of those left behind. Changing in the term End of Life Care to Care of Dying Adults (as NICE have done) or Care towards the end of life (as the GMC did) would be an improvement.

Dr Adrian Treloar FRCP, MRCPsych, MRCGP is a consultant in Old Age Psychiatry and Dementia Care.

References

  1. Pullicino Rev Prof P, Burke W. (2026). Commentary on “A Catholic guide to End-of-Life decision making Catholic Medical Quarterly Volume 76: (3) August 2026 pp18-19.
  2. Pullicino Rev Prof P, (2026). End of life “Care”, euthanasia and assisted  dying. Catholic Medical Quarterly Volume 76: (2) May 2026 pp18-19.
  3. Jon Rogers (2026). Good clinical care at end of life: a response to Fr Pullicino. Catholic Medical Quarterly Volume 76: (4) November 2026
  4. Jon Rogers (2026). In response to Drs Pullicino and Burke. Catholic Medical Quarterly Volume 76: (4) November 2026
  5. Treloar A (2020) Coronavirus and Access to Treatment: grave concerns and call for a public inquiry. Catholic Medical Quarterly Volume 70 (3) August 2020
  6. Rockwood scale https://www.bgs.org.uk/sites/default/files/content/attachment/2018-07-05/rockwood_cfs.pdf
  7. O’Donnell Charlie. (2026). End of Life Care – a perspective from a Catholic intensivist and emergency physician. Catholic Medical Quarterly Volume 76: (4) November 2026
  8. Bogle J. (2026). A timely warning about end of life care practices. Catholic Medical Quarterly Volume 76: (4) November 2026
  9. Treloar A. Continuous deep sedation. Dutch research reflects problems with the Liverpool care pathway BMJ 2008; 336:905 doi: https://doi.org/10.1136/bmj.39556.400370.80 (Published 24 April 2008)
  10. Bowers et al (2019) Anticipatory syringe drivers: a step too far. BMJ Support Palliat Care. 2019 Jun 1;9(2):149–150. doi: 10.1136/bmjspcare-2018-001728